Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2009
Emergent BioSolutions Inc. (NYSE:EBS) announced today its financial results for the second quarter and six months ended June 30,...
Emergent BioSolutions to Release Second Quarter 2009 Financial Results and Conduct a Conference Call on August 6, 2009
Emergent BioSolutions Inc. (NYSE: EBS) announced today it will report financial results for second quarter 2009 on Thursday, August 6, 2009, after market...
Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in Greater Washington
Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad El-Hibri, its chairman and chief executive officer, received the Ernst & Young Entrepreneur of the Year® 2009 Award in the Technology...
Emergent BioSolutions Chief Financial Officer, Don Elsey, Named SmartCFO of the Year
Emergent BioSolutions Inc. (NYSE:EBS) announced today that Don Elsey, its chief financial officer (CFO) and senior vice president of finance and administration, has been named 2009 SmartCFO of the...
Emergent BioSolutions Meets With FDA To Review Regulatory Strategy for Recombinant Anthrax Vaccine
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has met with the U.S. Food and Drug Administration (FDA) to review Emergent’s regulatory strategy for the development of its...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years
Emergent BioSolutions Inc. (NYSE:EBS) announced today that its flagship product, BioThrax® (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and...
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be webcasting its presentation at the following two investor conferences during the month of June...
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 21, 2009 at 10:00 am Eastern
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it will hold its Annual Meeting of Stockholders on Thursday, May 21, 2009 beginning at 10:00 am Eastern Time at the Crowne Plaza Hotel, 3...
Emergent BioSolutions Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract with HHS
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) a Development Plan for the company’s Recombinant Protective Antigen (rPA)...
Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington
Emergent BioSolutions Inc. (NYSE:EBS) announced today that its chairman and chief executive officer, Mr. Fuad El-Hibri, is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award in...
Emergent BioSolutions Launches BioThrax.com, an Educational Website about BioThrax (Anthrax Vaccine Adsorbed) and Anthrax Disease
Emergent BioSolutions Inc. (NYSE:EBS) announced today the launch of www.biothrax.com, a website that provides information about BioThrax® (Anthrax Vaccine Adsorbed), the only vaccine licensed by the...
Emergent BioSolutions Reports Financial Results for First Quarter 2009
Emergent BioSolutions Inc. (NYSE:EBS) announced today its financial results for the first quarter ended March 31,...